Gender differences in cardiac ischemic injury and protection - Experimental aspects

Experimental Biology and Medicine

Volumn 234, Issue 9, 2009, Pages 1011-1019

  Ostadal, Bohuslav ^a   Netuka, Ivan ^a,b   Maly, Jiri ^a,b   Besik, Josef ^a,b   Ostadalova, Ivana ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Adaptive response; Cardioprotection; Gender differences; Ischemia reperfusion injury

Indexed keywords

ANDROGEN; CALCIUM; ESTROGEN; HORMONE RECEPTOR; REGULATOR PROTEIN; SEX HORMONE; STEROID HORMONE;

ADAPTIVE BEHAVIOR; AGING; CALCIUM METABOLISM; CELL LOSS; CHRONIC DISEASE; DOG; DRUG METABOLISM; EXPERIMENTAL STUDY; FEMALE ANIMAL; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HYPOXIA; ISCHEMIC PRECONDITIONING; MENOPAUSE; MITOCHONDRION; NONHUMAN; RABBIT; REPERFUSION INJURY; SEX DIFFERENCE; SHORT SURVEY; TISSUE GROWTH;

ANIMALS; DOGS; FEMALE; HEART; HUMANS; MALE; MICE; MYOCARDIAL REPERFUSION INJURY; RABBITS; RATS; SEX FACTORS;

CANIS FAMILIARIS; MUS; ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 70349159587     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0812-MR-362     Document Type: Short Survey

References (70)

1. Leinwand LA. Sex is a potent modifier of the cardiovascular system. J Clin Invest 112:302-304, 2003.
2. Regitz-Zagrosek V. Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat Rev Drug Discov 5:425-439, 2006. (Pubitemid 43904934)
3. Hulley S, Grandy D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280:605-612, 1998. (Pubitemid 28502636)
4. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Hutchinson F, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized control trial. JAMA 288:321-333, 2002. (Pubitemid 34761611)
5. Ouyang P, Michos ED, Karas RH. Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions. J Am Coll Cardiol 47:1741-1753, 2006.
6. De Simone G, Devreux RB, Daniels SR, Meyer RA. Gender differences in left ventricular growth. Hypertension 26:979-983, 1995.
7. Olivetti G, Giordano G, Corradi D, Melissati M, Lagrasta C, Gambert SR, Anversa P. Gender differences and aging: effects on the human heart. J Am Coll Cardiol 26:1068-1079, 1995.
8. Zhang XP, Vatner SF, Shen YT, Rossi F, Tian Y, Peppas A, Resuello RRG, Natividad FF, Vatner DE. Increased apoptosis and myocyte enlargement with decreased cardiac mass; distinctive features of the aging male, but not female, monkey heart. J Mol Cell Cardiol 43:487-491, 2007. (Pubitemid 47451421)
9. Mallat Z, Fornes P, Costagliola R, Esposito B, Belmin J, Lecomte D, Tedgui A. Age and gender effect on cardiomyocyte apoptosis in the normal human heart. J Gerontol 56A:M719-M723, 2001. (Pubitemid 33043483)
10. Boddaert J, Mallat Z, Fornes P, Esposito B, Lecomte D, Verny M, Tedgui A, Belmin J. Age and gender effects on apoptosis in the human coronary arterial wall. Mech Ageing Dev 126:678-684, 2005. (Pubitemid 40693291)
11. Bazett H. An analysis of the time-relations of electrocardiograms. Heart 7:353-370, 1920.
12. Liu XK, Wang W, Ebert SN, Franz MR, Katchman A, Woosley RL. Female gender a risk factor for torsades de pointes in an in vitro animal model. J Cardiovasc Pharmacol 34:287-294, 1999. (Pubitemid 29350511)
13. Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res 53:688-708, 2002.
14. Grandi AM, Venco A, Barzizza F, Scalise F, Pantaleo P, Finardi G. Influence of age and sex on left ventricular anatomy and function in normals. Cardiology 81:8-13, 1992.
15. Capasso JM, Remily RM, Smith RH, Sonneblick EH. Sex differences in myocardial contractility in the rat. Basic Res Cardiol 78:156-171, 1983.
16. 2+ channel modulation. Eur J Pharmacol 586:288-292, 2008.
17. Schaible TF, Scheuer J. Comparison of heart function in male and female rats. Basic Res Cardiol 79:402-412, 1984. (Pubitemid 14053177)
18. Leblanc N, Chartier D, Gosselin H, Rouleau JL. Age and gender differences in excitation-contraction coupling of the rat ventricle. J Physiol 511:533-548, 1998. (Pubitemid 28444621)
19. Petre RE, Quaile MP, Rossman EI, Ratcliffe SJ, Bailey BA, Houser SR, Margulies KB. Sex-based differences in myocardial contractile reserve. Am J Physiol Regul Integr Comp Physiol 292:R810-R818, 2007. (Pubitemid 46207734)
20. Ganten U, Schroder G, Witt M, Zimmermann F, Ganten D, Stock G. Sexual dimorphism of blood pressure in spontaneously hypertensive rats: effects of anti-androgen treatment. J Hypertens 7:721-726, 1989. (Pubitemid 19230550)
21. Chu SH, Sutherland K, Beck J, Kowalski J, Goldspink P, Schwertz D. Sex differences in expression of calcium-handling proteins and beta-adrenergic receptors in rat heart ventricle. Life Sci 76:2735-2749, 2005. (Pubitemid 40404060)
22. 2+ uptake in cardiac mitochondria. J Mol Cell Cardiol 37:507-513, 2004.
23. 2 production and oxidative damage. Cardiovasc Res 74:456-465, 2007.
24. Duvall WL. Cardiovascular disease in women. Mt Sinai J Med 70:293-305, 2003.
25. Fejfar Z. Prevention against ischaemic heart disease: a critical review. In: Oliver MF, Ed. Modern Trends in Cardiology-3. London and Boston: Butterworths, pp465-499, 1975.
26. Ostadal B, Prochazka J, Pelouch V, Urbanova D, Widimsky J. Comparison of cardiopulmonary responses of male and female rats to intermittent high altitude hypoxia. Physiol Bohemoslov 33:129-138, 1984. (Pubitemid 14107670)
27. Ostadal B, Kolar F. Cardiac adaptation to chronic high altitude hypoxia. Respir Physiol Neurobiol 158:224-236, 2007.
28. ATP channel blockade in rat. Am J Physiol Heart Circ Physiol 290:H2644-H2647, 2006.
29. Besik J, Szarszoi O, Kunes J, Netuka I, Maly J, Kolar F, Pirk J, Ostadal B. Tolerance to acute ischemia in adult male and female spontaneously hypertensive rats. Physiol Res 56:267-274, 2007.
30. Hale SL, Birnbaum Y, Kloner RA. β-Estradiol, but not α-estradiol, reduced myocardial necrosis in rabbits after ischemia and reperfusion. Am Heart J 132:258-262, 1996. (Pubitemid 26292388)
31. Netuka I, Szarszoi O, Maly J, Besik J, Neckar J, Ostadalova I, Pirk J, Ostadal B. Effect of perinatal hypoxia on cardiac tolerance to acute ischaemia in adult male and female rats. Clin Exp Pharmacol Physiol 33:714-719, 2006. (Pubitemid 44060763)
32. Murphy E, Steenbergen C. Cardioprotection in females: a role for nitric oxide and altered gene expression. Heart Fail Rev 12:293-300, 2007. (Pubitemid 350176702)
33. Chen JQ, Yager JD, Russo J. Regulation of mitochondrial respiratory chain structure and function by estrogens/estrogen receptors and potential physiological/pathophysiological implications. Biochim Biophys Acta 1746:1-17, 2005. (Pubitemid 41484081)
34. Arias-Loza PA, Jazbutyte V, Pelzer T. Genetic and pharmacologic strategies to determine the function of estrogen receptor α and estrogen receptor β in the cardiovascular system. Gend Med 5:S34-S45, 2007.
35. Booth EA, Obeid NR, Lucchesi BR. Activation of estrogen receptor-alpha protects the in vivo rabbit heart from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 289:H2039-H2047, 2005.
36. Wang M, Crisostomo P, Wairiuko GM, Meldrum DR. Estrogen receptor-alpha mediates acute myocardial protection in females. Am J Physiol Heart Circ Physiol 290:H2204-H2209, 2006. (Pubitemid 43846046)
37. Zhai P, Eurell TE, Cooke PS, Lubahn DB, Gross DR. Myocardial ischemia-reperfusion injury in estrogen receptor-alpha knockout and wild-type mice. Am J Physiol Heart Circ Physiol 278:H1640-H1647, 2000. (Pubitemid 30395577)
38. Jeanes HL, Tabor K, Black D, Ederveen A, Gray GA. Oestrogen-mediated cardioprotection following ischaemia and reperfusion is mimicked by an oestrogen receptor (ER) α agonist and unaffected by an ERβ antagonist. J Endocrinol 197:493-501, 2008. (Pubitemid 351803954)
39. Gabel SA, Walker VR, London RE, Steenbergen C, Korach KS, Murphy E. Estrogen receptor beta mediates gender differences in ischemia/reperfusion injury. J Mol Cell Cardiol 38:289-297, 2005. (Pubitemid 40215198)
40. Nikolic I, Liu D, Bell J, Collins J, Steenbergen C, Murphy E. Treatment with an estrogen receptor beta selective agonist is cardioprotective. J Mol Cell Cardiol 42:769-780, 2007. (Pubitemid 46527602)
41. Di Lisa F. A female way to protect the heart. Say NO to calcium. Circ Res 98:298-300, 2006.
42. 2+ channel falphag 1 subunit and reduced ischemia-reperfusion injury. Circ Res 98:403-411, 2006.
43. 2+ loading and adrenergic stimulation reveal male/female differences in susceptibility to ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 283:H481-H489, 2002.
44. Wang C, Chiari PC, Weihrauch D, Kroliowski JG, Warltier DC, Kersten JR, Pratt PF, Pagel PS. Gender-specificity of delayed preconditioning by isoflurane in rabbits: potential role of endothelial nitric oxide synthase. Anesth Analg 103:274-280, 2006. (Pubitemid 44140620)
45. Lee TM, Su SF, Tsai CC, Lee YT, Tsai CH. Cardioprotective effect of 17 beta-estradiol produced by activation of mitochondrial ATP-sensitive K+ channels in canine hearts. J Mol Cell Cardiol 32:1147-1158, 2000.
46. Bae S, Zhang L. Gender differences in cardioprotection against ischemia/reperfusion injury in adult rat hearts: focus on akt and protein kinase C signaling. J Pharmacol Exp Ther 315:1125-1135, 2005. (Pubitemid 41635399)
47. Camper-Kirby D, Welch S, Walker A, Shiraishi I, Setchell KDR, Schaefer E, Kajstura J, Anversa P, Sussman MA. Myocardial akt activation and gender: increased nuclear activity in females versus males. Circ Res 88:1020-1027, 2001. (Pubitemid 34137114)
48. Xu Y, Arenas IA, Armstrong SJ, Plahta WC, Xu H, Davidge ST. Estrogen improves cardiac recovery after ischemia/reperfusion by decreasing tumor necrosis factor-α. Cardiovasc Res 69:836-844, 2006. (Pubitemid 43227982)
49. Grohé C, Kahlert S, Löbbert K, Vetter H. Expression of oestrogen receptor α and β in rat heart: role of local oestrogen synthesis. J Endocrinol 156:R1-R7, 1998. (Pubitemid 28105832)
50. Tsang S, Wu S, Liu J, Wong TM. Testosterone protects rat hearts against ischaemic insults by enhancing the effects of alpha(1)-adrenoceptor stimulation. Brit J Pharmacol 153:693-709, 2008. (Pubitemid 351271765)
51. Mendelsohn ME. Molecular and cellular basis of cardiovascular gender differences. Science 308:1583-1587, 2005. (Pubitemid 40807497)
52. Humphreys RA, Kane KA, Parratt JR. The influence of maturation and gender on the anti-arrhythmic effect of ischaemic preconditioning in rats. Basic Res Cardiol 94:1-8, 1999.
53. Song X, Li G, Vaage J, Valen G. Effects of sex, gonadectomy, and oestrogen substitution on ischaemic preconditioning and ischaemia-reperfusion injury in mice. Acta Physiol Scand 177:459-466, 2003. (Pubitemid 36411583)
54. Crisostomo PR, Wang M, Wairiuko GM, Terrell AM, Meldrum DR. Postconditioning in females depends on injury severity. J Surg Res 134:342-347, 2006. (Pubitemid 44092812)
55. 5-enkephalin-induced cardioprotection: role of PI3K/Akt. Am J Physiol Heart Circ Physiol 294:H302-H310, 2008.
56. Turcato S, Turnbull L, Wang GY, Honbo N, Simpson PC, Karliner JS, Baker AJ. Ischemic preconditioning depends on age and gender. Basic Res Cardiol 101:235-243, 2006.
57. Ostadal B, Ostadalova I, Dhalla NS. Development of cardiac sensitivity to oxygen deficiency: comparative and ontogenetic aspects. Phys Rev 79:635-659, 1999. (Pubitemid 29330169)
58. Ostadalova I, Ostadal B, Kolar F. Tolerance to ischaemia and ischaemic preconditioning in neonatal rat heart. J Mol Cell Cardiol 30:857-865, 1998. (Pubitemid 28190730)
59. Anversa P, Li P, Zhang X, Olivetti G, Capasso JM. Ischaemic myocardial injury and ventricular remodelling. Cardiovasc Res 27:145-157, 1993. (Pubitemid 23070318)
60. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81:1161-1172, 1990.
61. Aurigemma GP, Gaasch WH. Gender differences in older patients with pressure-overload hypertrophy of the left ventricle. Cardiology 86:310-317, 1995.
62. Douglas PS, Katz SE, Weinberg EO, Chen MH, Bishop SP, Lorell BH. Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. J Am Coll Cardiol 32:1118-1125, 1998.
63. Barker WH, Mullooly JP, Getchell W. Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990-1994. Circulation 113:799-805, 2006.
64. Guerra S, Leri A, Wang X, Finato N, Di Lorento C, Beltrami CA, Kajstura J, Anversa P. Myocyte death in the failing human heart is gender dependent. Circ Res 85:856-866, 1999. (Pubitemid 29504161)
65. Litwin SE, Katz SE, Litwin CM, Morgan JP, Douglas PS. Gender differences in postinfarction left ventricular remodeling. Cardiology 91:173-183, 1999. (Pubitemid 29454255)
66. Litwin SE. The rat model of postinfarction heart failure. Heart Fail 11:182-195, 1995.
67. Cavasin MA, Tao Z, Menon S, Yang XP. Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice. Life Sci 75:2181-2192, 2004. (Pubitemid 39127470)
68. Xu Y, Arenas IA, Armstrong SJ, Davidge ST. Estrogen modulation of left ventricular remodeling in the aged heart. Cardiovasc Res 57:388-394, 2003. (Pubitemid 36144217)
69. Jain M, Liao R, Podesser BK, Ngoy S, Apstein CS, Eberli FR. Influence of gender on the response to hemodynamic overload after myocardial infarction. Am J Physiol Heart Circ Physiol 283:H2544-H2550, 2002. (Pubitemid 35345961)
70. Shioura KM, Geenen DL, Goldspink PH. Sex-related changes in cardiac function following myocardial infarction in mice. Am J Physiol Regul Integr Comp Physiol 295:R528-R534, 2008.